PHARMACENTRIC SOLUTIONS LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Pharmacentric Solutions Limited. The company was founded 7 years ago and was given the registration number 10948509. The firm's registered office is in HODDESDON. You can find them at Unit 2, Tower House, Tower Centre, Hoddesdon, . This company's SIC code is 72110 - Research and experimental development on biotechnology.

Company Information

Name	:	PHARMACENTRIC SOLUTIONS LIMITED
Company Number	:	10948509
Company Type	:	PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status	:	Active
Incorporation Date	:	06 September 2017
Industry Codes	:	72110 - Research and experimental development on biotechnology

Office Address & Contact

Registered Address	:	Unit 2, Tower House, Tower Centre, Hoddesdon, England, EN11 8UR
Country Origin	:	ENGLAND
Telephone	:	Unreported
Email Address	:	Unreported
Website	:	Unreported
Social	:	Unreported

People with Significant Control

Dr Pauline Williams
Notified on	:	01 November 2022
Status	:	Active
Date of birth	:	March 1967
Nationality	:	British
Country of residence	:	England
Address	:	Unit 2, Tower House, Tower Centre, Hoddesdon, England, EN11 8UR
Nature of control	:	Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent Right to appoint and remove directors

Mr Gregor John Mclennan Anderson
Notified on	:	06 September 2017
Status	:	Active
Date of birth	:	May 1963
Nationality	:	British
Country of residence	:	England
Address	:	Unit 2, Tower House, Tower Centre, Hoddesdon, England, EN11 8UR
Nature of control	:	Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent Right to appoint and remove directors

Account Documents

Accounts

Last accounts submitted for period 31 March 2023 (1 year ago)
Accounts type was MICRO
Next accounts dated 31 March 2024
Due by 31 December 2024 (1 months remaining)

Confirmation Statement

Last submitted on 14 October 2023 (1 year ago)
Next confirmation dated 14 October 2024
Due by 28 October 2024 (0 months remaining)